IL126893A - Sulfated pentasaccharide derivatives and pharmaceutical compositions containing them - Google Patents

Sulfated pentasaccharide derivatives and pharmaceutical compositions containing them

Info

Publication number
IL126893A
IL126893A IL12689398A IL12689398A IL126893A IL 126893 A IL126893 A IL 126893A IL 12689398 A IL12689398 A IL 12689398A IL 12689398 A IL12689398 A IL 12689398A IL 126893 A IL126893 A IL 126893A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
sulfated pentasaccharide
derivatives
sulfated
Prior art date
Application number
IL12689398A
Other languages
English (en)
Other versions
IL126893A0 (en
Original Assignee
Akzo Nobel Nv
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv, Sanofi Synthelabo filed Critical Akzo Nobel Nv
Publication of IL126893A0 publication Critical patent/IL126893A0/xx
Publication of IL126893A publication Critical patent/IL126893A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL12689398A 1997-11-19 1998-11-04 Sulfated pentasaccharide derivatives and pharmaceutical compositions containing them IL126893A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97203613 1997-11-19

Publications (2)

Publication Number Publication Date
IL126893A0 IL126893A0 (en) 1999-09-22
IL126893A true IL126893A (en) 2003-05-29

Family

ID=8228942

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12689398A IL126893A (en) 1997-11-19 1998-11-04 Sulfated pentasaccharide derivatives and pharmaceutical compositions containing them

Country Status (34)

Country Link
US (1) US6174863B1 (pl)
EP (1) EP1032579B1 (pl)
JP (1) JP4364959B2 (pl)
KR (1) KR100518497B1 (pl)
CN (1) CN1177855C (pl)
AR (1) AR017640A1 (pl)
AT (1) ATE239030T1 (pl)
AU (1) AU746959B2 (pl)
BR (1) BRPI9804699B1 (pl)
CA (1) CA2253113C (pl)
CO (1) CO4990974A1 (pl)
CZ (1) CZ293639B6 (pl)
DE (1) DE69814140T2 (pl)
DK (1) DK1032579T3 (pl)
EE (1) EE04348B1 (pl)
ES (1) ES2198081T3 (pl)
HK (1) HK1028406A1 (pl)
HU (1) HU226685B1 (pl)
ID (1) ID21287A (pl)
IL (1) IL126893A (pl)
IS (1) IS2527B (pl)
NO (1) NO310723B1 (pl)
NZ (1) NZ332834A (pl)
PE (1) PE134799A1 (pl)
PL (1) PL188229B1 (pl)
PT (1) PT1032579E (pl)
RU (1) RU2210573C2 (pl)
SG (1) SG72889A1 (pl)
SK (1) SK284134B6 (pl)
TR (1) TR199802372A2 (pl)
TW (1) TW448180B (pl)
UA (1) UA49089C2 (pl)
WO (1) WO1999025720A1 (pl)
ZA (1) ZA9810559B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI289566B (en) * 1999-12-07 2007-11-11 N.V.Organon Antithrombotic compound
AU2002243630A1 (en) * 2001-01-23 2002-08-06 Massachusetts Institute Of Technology Solid- and solution -phase synthesis of heparin and other glycosaminoglycans
PT1569912E (pt) 2002-12-03 2015-09-15 Pharmacyclics Llc Derivados 2-(2-hidroxibifenil-3-il)-1h-benzoimidazole-5- carboxamidina como inibidores do fator viia
CN1317287C (zh) * 2003-04-18 2007-05-23 山东大学 一种多硫酸寡糖及其制备方法
CN103788141B (zh) * 2004-03-04 2016-08-17 普罗吉恩制药有限公司 硫酸化寡聚糖衍生物
CN102046781A (zh) 2008-05-30 2011-05-04 动量制药公司 糖结构以及制造和使用此类结构的方法
EP2323605A4 (en) * 2008-09-10 2014-02-05 Syneron Medical Ltd TRANSDERMAL RELEASE OF OLIGOSACCHARIDES
EP2464668B1 (en) * 2009-07-31 2022-12-07 Reliable Biopharmaceutical Corporation Process for preparing fondaparinux sodium and intermediates useful in the synthesis thereof
US8420790B2 (en) 2009-10-30 2013-04-16 Reliable Biopharmaceutical Corporation Efficient and scalable process for the manufacture of Fondaparinux sodium
ES2560467T3 (es) * 2011-06-17 2016-02-19 Carbomimetics Pentasacáridos sintéticos que tienen vida media corta y alta actividad
EP2578594A1 (en) 2011-10-04 2013-04-10 Sanofi Process of preparation of L-iduronic acid comprising a decarboxylation/intramolecular cyclisation tandem reaction
US9873712B2 (en) * 2014-10-03 2018-01-23 Amphastar Pharmaceuticals, Inc. Method of purifying idraparinux sodium
CN109134555B (zh) * 2017-06-15 2021-09-28 南京正大天晴制药有限公司 抗凝血的五糖类化合物及其制备方法和医药用途
CN109134553B (zh) * 2017-06-15 2021-09-28 南京正大天晴制药有限公司 抗凝血的五糖类化合物及其制备方法和医药用途
CN109134554B (zh) * 2017-06-15 2021-09-28 南京正大天晴制药有限公司 抗凝血的五糖类化合物及其制备方法和医药用途
WO2021043631A1 (en) 2019-09-02 2021-03-11 Hepoligo Solutions Aps Intermediates useful for preparing iduronic acid containing di- and polysaccharides
WO2021211441A1 (en) * 2020-04-13 2021-10-21 The Board Of Regents Of The University Of Oklahoma Modified sugar polymers with low anticoagulant activity and therapeutic activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300099A1 (en) * 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
ES2060284T3 (es) * 1990-04-23 1994-11-16 Sanofi Elf Un procedimiento para la preparacion de un derivado de carbohidrato que comprende una unidad de trisacarido.
IL102758A (en) * 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
HU226685B1 (en) 2009-06-29
AU746959B2 (en) 2002-05-09
JPH11217394A (ja) 1999-08-10
DE69814140D1 (de) 2003-06-05
PE134799A1 (es) 2000-01-07
TW448180B (en) 2001-08-01
HU9802663D0 (en) 1999-01-28
EP1032579B1 (en) 2003-05-02
HK1028406A1 (en) 2001-02-16
EP1032579A1 (en) 2000-09-06
CO4990974A1 (es) 2000-12-26
BRPI9804699B1 (pt) 2016-07-12
NO985365L (no) 1999-05-20
TR199802372A2 (xx) 1999-06-21
WO1999025720A1 (en) 1999-05-27
PT1032579E (pt) 2003-08-29
SK7362000A3 (en) 2000-10-09
RU2210573C2 (ru) 2003-08-20
PL188229B1 (pl) 2004-12-31
PL329789A1 (en) 1999-05-24
NZ332834A (en) 2000-01-28
IS5485A (is) 2000-05-09
EE04348B1 (et) 2004-08-16
HUP9802663A3 (en) 2000-04-28
DK1032579T3 (da) 2003-08-25
AR017640A1 (es) 2001-09-12
CA2253113C (en) 2008-06-17
AU9324298A (en) 1999-06-17
CZ293639B6 (cs) 2004-06-16
KR19990045312A (ko) 1999-06-25
BR9804699A (pt) 2000-12-26
NO985365D0 (no) 1998-11-18
SK284134B6 (sk) 2004-09-08
CZ376198A3 (cs) 1999-06-16
HUP9802663A2 (hu) 1999-06-28
JP4364959B2 (ja) 2009-11-18
CA2253113A1 (en) 1999-05-19
US6174863B1 (en) 2001-01-16
SG72889A1 (en) 2000-05-23
IS2527B (is) 2009-07-15
EE200000301A (et) 2001-12-17
CN1177855C (zh) 2004-12-01
ES2198081T3 (es) 2004-01-16
CN1222524A (zh) 1999-07-14
KR100518497B1 (ko) 2005-12-16
ID21287A (id) 1999-05-20
IL126893A0 (en) 1999-09-22
DE69814140T2 (de) 2004-04-08
UA49089C2 (uk) 2002-09-16
NO310723B1 (no) 2001-08-20
ZA9810559B (en) 1999-05-15
ATE239030T1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
IL116851A (en) 3-arylidene-2-oxindole derivatives and pharmaceutical compositions containing them
IL123887A0 (en) Dithiolan derivatives their use and pharmaceutical compositions containing the same
HUP0001309A3 (en) 1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them
HUP9900424A2 (hu) Tiazolil-benzfurán-származékok és a vegyületeket tartalmazó gyógyászati készítmények
IL135646A0 (en) α-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
HUP0101381A3 (en) Benzofurylpyrone derivatives and pharmaceutical compositions containing them
IL126893A (en) Sulfated pentasaccharide derivatives and pharmaceutical compositions containing them
HUP0002324A3 (en) Benzimidazole derivatives and pharmaceutical compositions containing them
HUP9800147A3 (en) Isoxasol-and crotonoil-amide derivatives and pharmaceutical and diagnostical compositions containing them
IL137740A0 (en) Anticonvulsant drugs and pharmaceutical compositions containing them
HUP0100085A3 (en) Biphenylamidine derivatives and pharmaceutical compositions containing them
ZA967800B (en) Heteroaryllsubstituted acryloylguanidine derivatives and pharmaceutical compositions comprising them
HUP9802132A3 (en) Biphenyl-sulfonyl-cyanamides, their use and pharmaceutical compositions containing them
HUP0002331A3 (en) 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof
HUP0101701A3 (en) Substituted betha-alanines and pharmaceutical compositions comprising them
IL131846A0 (en) Novel pyridine derivatives and pharmaceutical compositions containing them
IL120669A0 (en) Benzylamine derivatives and pharmaceutical compositions containing them
IL141654A0 (en) Pyranose derivatives and pharmaceutical compositions containing the same
IL120722A0 (en) Carbohydrate derivatives and pharmaceutical compositions containing them
IL136045A0 (en) Pyridylpyrrole derivatives and pharmaceutical compositions containing the same
GR3036638T3 (en) Novel pyridine derivatives and pharmaceutical compositions containing them
HUP0001010A3 (en) Benzimidazole derivatives and pharmaceutical compositions containing them
HUP9802590A3 (en) Indan-, benzothiophene-, benzofuran- and indolesulfonamide derivatives, their use and pharmaceutical compositions containing them
HU9702348D0 (en) New anticoagulant glycosides and pharmaceutical compositions containing them
ZA982457B (en) Pharmaceutical compositions containing propanaminde derivatives and cyclodextrin

Legal Events

Date Code Title Description
HCA Change of name of proprietor(s) after amalgamation
FF Patent granted
KB Patent renewed
KB Patent renewed
FF Patent granted
KB Patent renewed
KB Patent renewed
EXP Patent expired